Xiaoting (Eileen) He

● 10+ years of full-stage clinical development experience: Led 14 Phase I-II oncology trials and spearheaded a global multi-center Phase III gynecological oncology trial, simultaneously advancing NMPA/FDA/EMA filings. ● Proficient in multi-country regulatory communication: Led CDE Pre-NDA/NDA communications, participated in EMA SA meetings (Sweden/UK), and FDA Type C meeting/IND submission; familiar with multi-country filing regulations to efficiently advance registration processes. ● Outstanding team management experience (over 5 years): Managed team performance and conducted training; organized internal professional training in gynecology/oncology, with mature experience in mentoring and overall coordination. ● Strong cross-domain achievements: Covers gynecological health, multi-system oncology (urological/digestive/breast) and rare diseases; has published an SCI paper (IF 15), delivered 6 international conference presentations, and won several honors including the Merck Serono global cooperation award and the Asieris CEO Award. ● Solid academic and clinical foundation: Holds a Bachelor of Clinical Medicine and a Master of Obstetrics and Gynecology from Tongji University, with supplementary German studies. Served as a Resident Physician in Obstetrics and Gynecology at Tongji Hospital participating in the diagnosis, treatment and surgery of gynecological tumors.